IBDEI223 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,32818,2)
;;=^5005879
;;^UTILITY(U,$J,358.3,32819,0)
;;=H40.43X2^^128^1670^29
;;^UTILITY(U,$J,358.3,32819,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32819,1,3,0)
;;=3^Inflam GLC,OU,Moderate Stage
;;^UTILITY(U,$J,358.3,32819,1,4,0)
;;=4^H40.43X2
;;^UTILITY(U,$J,358.3,32819,2)
;;=^5005880
;;^UTILITY(U,$J,358.3,32820,0)
;;=H40.43X3^^128^1670^30
;;^UTILITY(U,$J,358.3,32820,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32820,1,3,0)
;;=3^Inflam GLC,OU,Severe Stage
;;^UTILITY(U,$J,358.3,32820,1,4,0)
;;=4^H40.43X3
;;^UTILITY(U,$J,358.3,32820,2)
;;=^5005881
;;^UTILITY(U,$J,358.3,32821,0)
;;=H40.43X4^^128^1670^31
;;^UTILITY(U,$J,358.3,32821,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32821,1,3,0)
;;=3^Inflam GLC,OU,Indeterminate Stage
;;^UTILITY(U,$J,358.3,32821,1,4,0)
;;=4^H40.43X4
;;^UTILITY(U,$J,358.3,32821,2)
;;=^5005882
;;^UTILITY(U,$J,358.3,32822,0)
;;=H40.42X0^^128^1670^22
;;^UTILITY(U,$J,358.3,32822,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32822,1,3,0)
;;=3^Inflam GLC,OS,Stage Unspec
;;^UTILITY(U,$J,358.3,32822,1,4,0)
;;=4^H40.42X0
;;^UTILITY(U,$J,358.3,32822,2)
;;=^5005874
;;^UTILITY(U,$J,358.3,32823,0)
;;=H40.42X1^^128^1670^23
;;^UTILITY(U,$J,358.3,32823,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32823,1,3,0)
;;=3^Inflam GLC,OS,Mild Stage
;;^UTILITY(U,$J,358.3,32823,1,4,0)
;;=4^H40.42X1
;;^UTILITY(U,$J,358.3,32823,2)
;;=^5005875
;;^UTILITY(U,$J,358.3,32824,0)
;;=H40.42X2^^128^1670^24
;;^UTILITY(U,$J,358.3,32824,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32824,1,3,0)
;;=3^Inflam GLC,OS,Moderate Stage
;;^UTILITY(U,$J,358.3,32824,1,4,0)
;;=4^H40.42X2
;;^UTILITY(U,$J,358.3,32824,2)
;;=^5005876
;;^UTILITY(U,$J,358.3,32825,0)
;;=H40.42X3^^128^1670^25
;;^UTILITY(U,$J,358.3,32825,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32825,1,3,0)
;;=3^Inflam GLC,OS,Severe Stage
;;^UTILITY(U,$J,358.3,32825,1,4,0)
;;=4^H40.42X3
;;^UTILITY(U,$J,358.3,32825,2)
;;=^5133506
;;^UTILITY(U,$J,358.3,32826,0)
;;=H40.42X4^^128^1670^26
;;^UTILITY(U,$J,358.3,32826,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32826,1,3,0)
;;=3^Inflam GLC,OS,Indeterminate Stage
;;^UTILITY(U,$J,358.3,32826,1,4,0)
;;=4^H40.42X4
;;^UTILITY(U,$J,358.3,32826,2)
;;=^5005877
;;^UTILITY(U,$J,358.3,32827,0)
;;=H40.41X0^^128^1670^17
;;^UTILITY(U,$J,358.3,32827,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32827,1,3,0)
;;=3^Inflam GLC,OD,Stage Unspec
;;^UTILITY(U,$J,358.3,32827,1,4,0)
;;=4^H40.41X0
;;^UTILITY(U,$J,358.3,32827,2)
;;=^5005870
;;^UTILITY(U,$J,358.3,32828,0)
;;=H40.41X1^^128^1670^18
;;^UTILITY(U,$J,358.3,32828,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32828,1,3,0)
;;=3^Inflam GLC,OD,Mild Stage
;;^UTILITY(U,$J,358.3,32828,1,4,0)
;;=4^H40.41X1
;;^UTILITY(U,$J,358.3,32828,2)
;;=^5005871
;;^UTILITY(U,$J,358.3,32829,0)
;;=H40.41X2^^128^1670^19
;;^UTILITY(U,$J,358.3,32829,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32829,1,3,0)
;;=3^Inflam GLC,OD,Moderate Stage
;;^UTILITY(U,$J,358.3,32829,1,4,0)
;;=4^H40.41X2
;;^UTILITY(U,$J,358.3,32829,2)
;;=^5005872
;;^UTILITY(U,$J,358.3,32830,0)
;;=H40.41X3^^128^1670^20
;;^UTILITY(U,$J,358.3,32830,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32830,1,3,0)
;;=3^Inflam GLC,OD,Severe Stage
;;^UTILITY(U,$J,358.3,32830,1,4,0)
;;=4^H40.41X3
;;^UTILITY(U,$J,358.3,32830,2)
;;=^5133505
;;^UTILITY(U,$J,358.3,32831,0)
;;=H40.41X4^^128^1670^21
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI223 3799 printed Apr 09, 2024@21:30:15 Page 2
IBDEI223 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,32818,2)
+2 ;;=^5005879
+3 ;;^UTILITY(U,$J,358.3,32819,0)
+4 ;;=H40.43X2^^128^1670^29
+5 ;;^UTILITY(U,$J,358.3,32819,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,32819,1,3,0)
+8 ;;=3^Inflam GLC,OU,Moderate Stage
+9 ;;^UTILITY(U,$J,358.3,32819,1,4,0)
+10 ;;=4^H40.43X2
+11 ;;^UTILITY(U,$J,358.3,32819,2)
+12 ;;=^5005880
+13 ;;^UTILITY(U,$J,358.3,32820,0)
+14 ;;=H40.43X3^^128^1670^30
+15 ;;^UTILITY(U,$J,358.3,32820,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,32820,1,3,0)
+18 ;;=3^Inflam GLC,OU,Severe Stage
+19 ;;^UTILITY(U,$J,358.3,32820,1,4,0)
+20 ;;=4^H40.43X3
+21 ;;^UTILITY(U,$J,358.3,32820,2)
+22 ;;=^5005881
+23 ;;^UTILITY(U,$J,358.3,32821,0)
+24 ;;=H40.43X4^^128^1670^31
+25 ;;^UTILITY(U,$J,358.3,32821,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,32821,1,3,0)
+28 ;;=3^Inflam GLC,OU,Indeterminate Stage
+29 ;;^UTILITY(U,$J,358.3,32821,1,4,0)
+30 ;;=4^H40.43X4
+31 ;;^UTILITY(U,$J,358.3,32821,2)
+32 ;;=^5005882
+33 ;;^UTILITY(U,$J,358.3,32822,0)
+34 ;;=H40.42X0^^128^1670^22
+35 ;;^UTILITY(U,$J,358.3,32822,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,32822,1,3,0)
+38 ;;=3^Inflam GLC,OS,Stage Unspec
+39 ;;^UTILITY(U,$J,358.3,32822,1,4,0)
+40 ;;=4^H40.42X0
+41 ;;^UTILITY(U,$J,358.3,32822,2)
+42 ;;=^5005874
+43 ;;^UTILITY(U,$J,358.3,32823,0)
+44 ;;=H40.42X1^^128^1670^23
+45 ;;^UTILITY(U,$J,358.3,32823,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,32823,1,3,0)
+48 ;;=3^Inflam GLC,OS,Mild Stage
+49 ;;^UTILITY(U,$J,358.3,32823,1,4,0)
+50 ;;=4^H40.42X1
+51 ;;^UTILITY(U,$J,358.3,32823,2)
+52 ;;=^5005875
+53 ;;^UTILITY(U,$J,358.3,32824,0)
+54 ;;=H40.42X2^^128^1670^24
+55 ;;^UTILITY(U,$J,358.3,32824,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,32824,1,3,0)
+58 ;;=3^Inflam GLC,OS,Moderate Stage
+59 ;;^UTILITY(U,$J,358.3,32824,1,4,0)
+60 ;;=4^H40.42X2
+61 ;;^UTILITY(U,$J,358.3,32824,2)
+62 ;;=^5005876
+63 ;;^UTILITY(U,$J,358.3,32825,0)
+64 ;;=H40.42X3^^128^1670^25
+65 ;;^UTILITY(U,$J,358.3,32825,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,32825,1,3,0)
+68 ;;=3^Inflam GLC,OS,Severe Stage
+69 ;;^UTILITY(U,$J,358.3,32825,1,4,0)
+70 ;;=4^H40.42X3
+71 ;;^UTILITY(U,$J,358.3,32825,2)
+72 ;;=^5133506
+73 ;;^UTILITY(U,$J,358.3,32826,0)
+74 ;;=H40.42X4^^128^1670^26
+75 ;;^UTILITY(U,$J,358.3,32826,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,32826,1,3,0)
+78 ;;=3^Inflam GLC,OS,Indeterminate Stage
+79 ;;^UTILITY(U,$J,358.3,32826,1,4,0)
+80 ;;=4^H40.42X4
+81 ;;^UTILITY(U,$J,358.3,32826,2)
+82 ;;=^5005877
+83 ;;^UTILITY(U,$J,358.3,32827,0)
+84 ;;=H40.41X0^^128^1670^17
+85 ;;^UTILITY(U,$J,358.3,32827,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,32827,1,3,0)
+88 ;;=3^Inflam GLC,OD,Stage Unspec
+89 ;;^UTILITY(U,$J,358.3,32827,1,4,0)
+90 ;;=4^H40.41X0
+91 ;;^UTILITY(U,$J,358.3,32827,2)
+92 ;;=^5005870
+93 ;;^UTILITY(U,$J,358.3,32828,0)
+94 ;;=H40.41X1^^128^1670^18
+95 ;;^UTILITY(U,$J,358.3,32828,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,32828,1,3,0)
+98 ;;=3^Inflam GLC,OD,Mild Stage
+99 ;;^UTILITY(U,$J,358.3,32828,1,4,0)
+100 ;;=4^H40.41X1
+101 ;;^UTILITY(U,$J,358.3,32828,2)
+102 ;;=^5005871
+103 ;;^UTILITY(U,$J,358.3,32829,0)
+104 ;;=H40.41X2^^128^1670^19
+105 ;;^UTILITY(U,$J,358.3,32829,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,32829,1,3,0)
+108 ;;=3^Inflam GLC,OD,Moderate Stage
+109 ;;^UTILITY(U,$J,358.3,32829,1,4,0)
+110 ;;=4^H40.41X2
+111 ;;^UTILITY(U,$J,358.3,32829,2)
+112 ;;=^5005872
+113 ;;^UTILITY(U,$J,358.3,32830,0)
+114 ;;=H40.41X3^^128^1670^20
+115 ;;^UTILITY(U,$J,358.3,32830,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,32830,1,3,0)
+118 ;;=3^Inflam GLC,OD,Severe Stage
+119 ;;^UTILITY(U,$J,358.3,32830,1,4,0)
+120 ;;=4^H40.41X3
+121 ;;^UTILITY(U,$J,358.3,32830,2)
+122 ;;=^5133505
+123 ;;^UTILITY(U,$J,358.3,32831,0)
+124 ;;=H40.41X4^^128^1670^21
